These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 9502788

  • 21. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes.
    Alcendor RR, Kirshenbaum LA, Imai S, Vatner SF, Sadoshima J.
    Circ Res; 2004 Nov 12; 95(10):971-80. PubMed ID: 15486319
    [Abstract] [Full Text] [Related]

  • 22. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA, Lupu R.
    Int J Mol Med; 2005 Jan 12; 15(1):33-40. PubMed ID: 15583825
    [Abstract] [Full Text] [Related]

  • 23. Specific inhibitors of vacuolar H(+)-ATPase trigger apoptotic cell death of osteoclasts.
    Okahashi N, Nakamura I, Jimi E, Koide M, Suda T, Nishihara T.
    J Bone Miner Res; 1997 Jul 12; 12(7):1116-23. PubMed ID: 9200012
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Proton induces apoptosis of hypoxic tumor cells by the p53-dependent and p38/JNK MAPK signaling pathways.
    Lee KB, Kim KR, Huh TL, Lee YM.
    Int J Oncol; 2008 Dec 12; 33(6):1247-56. PubMed ID: 19020758
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1.
    Liang SX, Richardson DR.
    Carcinogenesis; 2003 Oct 12; 24(10):1601-14. PubMed ID: 12869419
    [Abstract] [Full Text] [Related]

  • 28. Bafilomycin A1 inhibits lysosomal, phagosomal, and plasma membrane H(+)-ATPase and induces lysosomal enzyme secretion in macrophages.
    Tapper H, Sundler R.
    J Cell Physiol; 1995 Apr 12; 163(1):137-44. PubMed ID: 7896890
    [Abstract] [Full Text] [Related]

  • 29. p53 mediates bcl-2 phosphorylation and apoptosis via activation of the Cdc42/JNK1 pathway.
    Thomas A, Giesler T, White E.
    Oncogene; 2000 Nov 02; 19(46):5259-69. PubMed ID: 11077443
    [Abstract] [Full Text] [Related]

  • 30. Characterization of distinct consecutive phases in non-genotoxic p53-induced apoptosis of Ewing tumor cells and the rate-limiting role of caspase 8.
    Kovar H, Jug G, Printz D, Bartl S, Schmid G, Wesierska-Gadek J.
    Oncogene; 2000 Aug 24; 19(36):4096-107. PubMed ID: 10962570
    [Abstract] [Full Text] [Related]

  • 31. Microtubules are involved in bafilomycin A1-induced tubulation and Rab5-dependent vacuolation of early endosomes.
    D'Arrigo A, Bucci C, Toh BH, Stenmark H.
    Eur J Cell Biol; 1997 Feb 24; 72(2):95-103. PubMed ID: 9157016
    [Abstract] [Full Text] [Related]

  • 32. Inhibitors of vacuolar-type H(+)-ATPase suppresses proliferation of cultured cells.
    Manabe T, Yoshimori T, Henomatsu N, Tashiro Y.
    J Cell Physiol; 1993 Dec 24; 157(3):445-52. PubMed ID: 8253855
    [Abstract] [Full Text] [Related]

  • 33. [A new strategy for the therapy of pancreatic cancer by proton pump inhibitor].
    Ohta T, Arakawa H, Futagami F, Fushida S, Kitagawa H, Kayahara M, Nagakawa T, Miyazaki I, Numata M, Ohkuma S.
    Gan To Kagaku Ryoho; 1996 Oct 24; 23(12):1660-4. PubMed ID: 8886039
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Inhibition of the vacuolar H(+)-ATPase with bafilomycin reduces delivery of internalized molecules from mature multivesicular endosomes to lysosomes in HEp-2 cells.
    van Deurs B, Holm PK, Sandvig K.
    Eur J Cell Biol; 1996 Apr 24; 69(4):343-50. PubMed ID: 8741216
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Destruxin B, a specific and readily reversible inhibitor of vacuolar-type H(+)-translocating ATPase.
    Muroi M, Shiragami N, Takatsuki A.
    Biochem Biophys Res Commun; 1994 Dec 15; 205(2):1358-65. PubMed ID: 7802670
    [Abstract] [Full Text] [Related]

  • 38. Enhanced expression of the human vacuolar H+-ATPase c subunit gene (ATP6L) in response to anticancer agents.
    Torigoe T, Izumi H, Ishiguchi H, Uramoto H, Murakami T, Ise T, Yoshida Y, Tanabe M, Nomoto M, Itoh H, Kohno K.
    J Biol Chem; 2002 Sep 27; 277(39):36534-43. PubMed ID: 12133827
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The role of vacuolar H(+)-ATPase in the control of intragranular pH and exocytosis in eosinophils.
    Kurashima K, Numata M, Yachie A, Sai Y, Ishizaka N, Fujimura M, Matsuda T, Ohkuma S.
    Lab Invest; 1996 Nov 27; 75(5):689-98. PubMed ID: 8941214
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.